Helen Marzec works at the intersection of behavioural science, narrative strategy, and venture markets to cultivate the conditions under which new technologies are trusted, adopted, and financed.

Her practice applies behavioural economics and evidence-driven analysis to the moments that determine commercial outcomes: how users form interpretations of value, how investors calibrate risk in high-uncertainty categories, and how markets construct belief around emerging systems. She operates under the conviction that behavioural strategy remains an under-explored competitive advantage; within this framework, new ventures can define their value proposition and positioning through methodologies that build distinct brands and positively influence human behaviour.

Her background spans venture capital due diligence, neuroscience-based consumer research, and startup strategy across North America, Europe, and Asia. Having supported early and growth-stage companies in biotech, healthtech, Web3, and identity infrastructure, her expertise lies in turning behavioural analyses into actionable insights.

She is based in Canada and operates internationally to achieve positive economic, financial, and health outcomes across venture-backed ecosystems.